Pfizer (PFE +2.4%) says during its earnings call that the FDA has requested additional analysis...

|About: Pfizer Inc. (PFE)|By:, SA News Editor

Pfizer (PFE +2.4%) says during its earnings call that the FDA has requested additional analysis of existing data in its tofacitinib New Drug Application. The company plans to release this information in early August and, given this timing, it anticipates that FDA may require additional time beyond the August 21 PDUFA date to review.